A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 36/074 (2006.01) A23L 1/30 (2006.01) A61K 8/97 (2006.01) A61P 1/02 (2006.01) A61P 1/04 (2006.01) A61P 17/00 (2006.01) A61P 17/02 (2006.01) A61P 19/02 (2006.01) A61P 19/10 (2006.01) A61P 29/00 (2006.01) A61P 35/04 (2006.01) A61P 43/00 (2006.01) A61Q 11/00 (2006.01) A61Q 19/08 (2006.01)
Patent
CA 2460834
The object of the present invention is to provide a preventive and relieving medicine for activated matrix metalloproteinase-causing disorders and diseases, which contains a solvent extract of Ganoderma mushroom. The preventive and relieving medicine for activated matrix metalloproteinase (MMP) -causing disorders and diseases according to the present invention contains the solvent extract of Ganoderma mushroom. The solvent extract of Ganoderma mushroom has MMP inhibiting behaviors and is effective for prevention, suppression, and symptomatic relief of various activated MMP-causing disorders and diseases, such as metastasis of cancers, ulceration, rheumatoid arthritis, osteoporosis, periodontitis, and aging of skin.
La présente invention concerne un médicament destiné à la prévention ou l'amélioration d'affections provoquées par l'accélération de la métalloprotéase matricielle caractérisée en ce qu'il contient un extrait au solvant de Ganoderma lucidum. En l'occurrence, ces médicaments pour prévenir ou améliorer des affections provoquées par l'accélération de la métalloprotéase matricielle (MMP) sont caractérisés en ce qu'on tire un extrait au solvant de Ganoderma lucidum. De par son aptitude à bloquer la MMP, l'extrait de Ganoderma lucidum convient à la prévention, au blocage ou à l'amélioration de symptômes de divers états pathologiques imputables à l'accélération de la MMP, et notamment la métastase du cancer, l'ulcération, l'arthrite rhumatoïde, l'ostéoporose, la parodontite, et le vieillissement de la peau, etc.
Hattori Koji
Mizutani Hiroshi
Osumi Kazuhisa
Gowling Lafleur Henderson Llp
Nippon Menard Cosmetic Co. Ltd.
Nonogawa Shoji Ltd.
LandOfFree
Matrix metalloproteinase inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Matrix metalloproteinase inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Matrix metalloproteinase inhibitor will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1766070